Background: The association between multiple sclerosis (MS) and the HLA-DRB1*15:01 haplotype has been proven to be strong, but its molecular basis remains unclear. Vitamin D receptor (VDR) gene variants and sex have been proposed to modulate this association.
Objectives: 1) Test the association of MS with *15:01 and VDR variants; 2) check whether VDR variants and/or sex modulate the risk conferred by *15:01; 3) study whether *15:01, VDR variants and/or sex affect HLA II gene expression.
Methods: Peripheral blood from 364 MS patients and 513 healthy controls was obtained and DNA and total RNA were extracted from leukocytes. HLA-DRB1, DRB5 and DQA1 gene expression measurements and *15:01 genotyping were performed by qPCR. VDR variants were genotyped by PCR-RFLP.
Results: Our data confirms that the *15:01 haplotype confers a higher risk of suffering from MS (OR = 1.364; 95% CI = 1.107–1.681). No association was found between VDR variants and MS, but they were shown to moderately modulate the risk conferred by *15:01. Sex confers a much stronger modulation and the *15:01-MS association seems to be female specific. A higher *15:01 frequency has been observed in Basques (45.1%). *15:01 positive samples showed a significant overexpression of DRB1 (p < 0.001), DRB5 (p < 0.001) and DQA1 (p = 0.004) in patients. DRB1 (p = 0.004) and DRB5 (p < 0.001) were also overexpressed in *15:01 controls.
Conclusions: We confirm the *15:01-MS association and support that it is female specific. The relevance of ethnic origin on association studies has also been highlighted. HLA-DRB1*15:01 seems to be a haplotype consistently linked to high HLA II gene expression.
OlerupOHillertJ. HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation. Tissue Antigens1991; 38: 1–15.
5.
GregersenJWKrancKRKeXSvendsenPMadsenLSThomsenAR. Functional epistasis on a common MHC haplotype associated with multiple sclerosis. Nature2006; 443: 574–577.
6.
PratETomaruUSabaterLParkDMGrangerRKruseN. HLA-DRB5*0101 and -DRB1*1501 expression in the multiple sclerosis-associated HLA-DR15 haplotype. J Neuroimmunol2005; 167: 108–119.
7.
FukazawaTYamasakiKItoHKikuchiSMinoharaMHoriuchiI. Both the HLA-CPB1 and -DRB1 alleles correlate with risk for multiple sclerosis in Japanese: clinical phenotypes and gender as important factors. Tissue Antigens2000; 55: 199–205.
8.
CeliusEGHarboHFEgelandTVartdalFVandvikBSpurkiandA. Sex and age at diagnosis are correlated with the HLA-DR2, DQ6 haplotype in multiple sclerosis. J Neurol Sci2000; 178: 132–135.
9.
HensiekAESawcerSJFeakesRDeansJManderAAkessonE. HLA-DR 15 is associated with female sex and younger age at diagnosis in multiple sclerosis. J Neurol Neurosurg Psychiatry2002; 72: 184–187.
10.
SmoldersJPeelenEThewissenMMenheerePCohen TervaertJWHuppertsR. The relevance of vitamin D receptor gene polymorphisms for vitamin D research in multiple sclerosis. Autoimmun Rev2009; 8: 621–626.
11.
PartridgeJMWeatherbySJWoolmoreJAHighlandDJFryerAAMannCL. Susceptibility and outcome in MS: associations with polymorphisms in pigmentation-related genes. Neurology2004; 62: 2323–2325.
12.
MamutseGWoolmoreJPyeEPartridgeJBoggildMYoungC. Vitamin D receptor gene polymorphism is associated with reduced disability in multiple sclerosis. Mult Scler2008; 14: 1280–1283.
13.
TajouriLOvcaricMCurtainRJohnsonMPGriffithsLRCsurhesP. Variation in the vitamin D receptor gene is associated with multiple sclerosis in an Australian population. J Neurogenet2005; 19: 25–38.
14.
AchironAGrottoIBalicerRMagalashviliDFeldmanAGurevichM. Microarray analysis identifies altered regulation of nuclear receptor family members in the pre-disease state of multiple sclerosis. Neurobiol Dis2010; 38: 201–209.
15.
CardonLRPalmerLJ. Population stratification and spurious allelic association. Lancet2003; 361: 598–604.
16.
ChoudhrySCoyleNETangHSalariKLindDClarkSL. Population stratification confounds genetic association studies among Latinos. Hum Genet2006; 118: 652–664.
17.
PolmanCHReingoldSCEdanGFilippiMHartungHPKapposL. Diagnostic criteria for multiple sclerosis: 2005 revisions to the ‘McDonald Criteria’. Ann Neurol2005; 58: 840–846.
18.
OtaeguiDSáenzAMartínez-ZabaletaMVillosladaPFernández-MancholaIAlvarezdeArcayaA. Mitochondrial haplogroups in Basque multiple sclerosis patients. Mult Scler2004; 10: 532–5.
19.
OkudaDTSrinivasanROksenbergJRGoodinDSBaranziniSEBeheshtianA. Genotype–phenotype correlations in multiple sclerosis: HLA genes influence disease severity inferred by 1HMR spectroscopy and MRI measures. Brain2009; 132: 250–259.
20.
ZivkovicMStankovicADincicEPopovicMPopovicSRaicevicR. The tag SNP for HLA-DRB1*1501, rs3135388, is significantly associated with multiple sclerosis susceptibility: cost-effective high-throughput detection by real-time PCR. Clin Chim Acta2009; 406: 27–30.
21.
BronsonPGCaillierSRamsayPPMcCauleyJLZuvichRLDe JagerPL. CIITA variation in the presence of HLA-DRB1*1501 increases risk for multiple sclerosis. Hum Mol Genet2010; 19: 2331–2340.
22.
StankovichJButzkuevenHMarriottMChapmanCTubridyNTaitBD. HLA-DRB1 associations with disease susceptibility and clinical course in Australians with multiple sclerosis. Tissue Antigens2009; 74: 17–21.
23.
KikuchiSFukazawaTNiinoMYabeIMiyagishiRHamadaT. Estrogen receptor gene polymorphism and multiple sclerosis in Japanese patients: interaction with HLA-DRB1*1501 and disease modulation. J Neuroimmunol2002; 128: 77–81.
24.
LincolnMRRamagopalanSVChaoMJHerreraBMDeLucaGCOrtonSM. Epistasis among HLA-DRB1, HLA-DQA1, and HLA-DQB1 loci determines multiple sclerosis susceptibility. Proc Natl Acad Sci U S A2009; 106: 7542–7547.
25.
FernandezOAntiguedadAPinto-MedelMJMendibeMMAcostaNOliverB. HLA class II alleles in patients with multiple sclerosis in the Biscay province (Basque Country, Spain). J Neurol2009; 256: 1977–1988.
26.
AllenMSandberg-WollheimMSjogrenKErlichHAPettersonUGyllenstenU. Association of susceptibility to multiple sclerosis in Sweden with HLA class II DRB1 and DQB1 alleles. Hum Immunol1994; 39: 41–48.
27.
Martinez-LasoJDeJDMartinez-QuilesNGomez-CasadoECuadradoEArnaiz-VillenaA. The contribution of the HLA-A, -B, -C and -DR, -DQ DNA typing to the study of the origins of Spaniards and Basques. Tissue Antigens1995; 45: 237–245.
28.
SchmidtAHSollochUVBaierDStahrAWassmuthREhningerG. Regional differences in HLA antigen and haplotype frequency distributions in Germany and their relevance to the optimization of hematopoietic stem cell donor recruitment. Tissue Antigens2010; 76: 362–379.
29.
SchwendimannRNAlekseevaN. Gender issues in multiple sclerosis. Int Rev Neurobiol2007; 79: 377–392.
30.
EikelenboomMJKillesteinJKragtJJUitdehaagBMPolmanCH. Gender differences in multiple sclerosis: cytokines and vitamin D. J Neurol Sci2009; 286: 40–42.
31.
AlaezCLinLFloresAVazquezMMunguiaAMignotE. Association of narcolepsy-cataplexy with HLA-DRB1 and DQB1 in Mexican patients: a relationship between HLA and gender is suggested. BMC Med Genet2008; 9: 79.
32.
CzajaAJDonaldsonPT. Gender effects and synergisms with histocompatibility leukocyte antigens in type 1 autoimmune hepatitis. Am J Gastroenterol2002; 97: 2051–2057.
33.
NiinoMFukazawaTYabeIKikuchiSSasakiHTashiroK. Vitamin D receptor gene polymorphism in multiple sclerosis and the association with HLA class II alleles. J Neurol Sci2000; 177: 65–71.
34.
RamagopalanSVMaugeriNJHandunnetthiLLincolnMROrtonSMDymentDA. Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D. PLoS Genet2009; 5: e1000369.
35.
AgliardiCGueriniFRSaresellaMCaputoDLeoneMAZanzotteraM. Vitamin D receptor (VDR) gene SNPs influence VDR expression and modulate protection from multiple sclerosis in HLA-DRB1*15-positive individuals. Brain Behav Immun2011; 25: 1460–1467.
36.
CaillierSJBriggsFCreeBABaranziniSEFernandez-VinaMRamsayPP. Uncoupling the roles of HLA-DRB1 and HLA-DRB5 genes in multiple sclerosis. J Immunol2008; 181: 5473–5480.
